PHARVARIS N V PHVS
COM · Common Stock · CUSIP N69605108
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $27.99.
Biggest buyers
| Foresite Capital Management IV, LLC | New | +3.3m |
| Bain Capital Life Sciences Investors, LLC | New | +3.2m |
| FMR LLC | New | +2.8m |
| VIKING GLOBAL INVESTORS LP | New | +2.4m |
| GENERAL ATLANTIC, L.P. | New | +2.4m |
| venBio Partners LLC | New | +2.3m |
| DEERFIELD MANAGEMENT COMPANY, L.P. | New | +1.0m |
| Venrock Adviser, LLC | New | +902.9k |
| Cormorant Asset Management, LP | New | +864.1k |
| Foresite Capital Management V, LLC | New | +664.1k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GENERAL ATLANTIC, L.P. 13G · passive investor filed 2026-08-14 | 7.6% |
| VIKING GLOBAL INVESTORS LP 13G · passive investor filed 2026-05-15 | 5.6% |
Fell to 5% or below in the last year: LSP V Cooperatieve U.A. (4.9%, 2026-07-31), Bain Capital Life Sciences Fund, L.P. (2.5%, 2026-02-17)
Insider purchases and sales in Q1 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2021.
Holders, Q1 2021
| Manager | Shares | Change |
|---|---|---|
| Foresite Capital Management IV, LLC 10.93% of their portfolio | 3.3m $91.3m | New |
| Bain Capital Life Sciences Investors, LLC 5.04% of their portfolio | 3.2m $89.0m | New |
| FMR LLC 0.01% of their portfolio | 2.8m $77.7m | New |
| GENERAL ATLANTIC, L.P. 0.79% of their portfolio | 2.4m $67.7m | New |
| VIKING GLOBAL INVESTORS LP 0.20% of their portfolio | 2.4m $67.9m | New |
| venBio Partners LLC 6.12% of their portfolio | 2.3m $64.4m | New |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.61% of their portfolio | 1.0m $28.9m | New |
| Venrock Adviser, LLC 2.75% of their portfolio | 902.9k $25.3m | New |
| Cormorant Asset Management, LP 0.69% of their portfolio | 864.1k $23.8m | New |
| Foresite Capital Management V, LLC 5.46% of their portfolio | 664.1k $18.6m | New |
| PICTET ASSET MANAGEMENT LTD 0.02% of their portfolio | 553.2k $15.5m | New |
| EVENTIDE ASSET MANAGEMENT, LLC 0.21% of their portfolio | 500.0k $14.0m | New |
| Avidity Partners Management LP 0.31% of their portfolio | 400.0k $11.2m | New |
| MILLENNIUM MANAGEMENT LLC 0.01% of their portfolio | 230.9k $6.5m | New |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.03% of their portfolio | 200.0k $5.6m | Not comparable |
| NOVO HOLDINGS A/S 0.06% of their portfolio | 50.0k $1.4m | New |
| CAAS CAPITAL MANAGEMENT LP 0.04% of their portfolio | 50.0k $1.4m | New |
| Marshall Wace North America L.P. 0.00% of their portfolio | 39.0k $1.1m | New |
| BlackRock Inc. 0.00% of their portfolio | 33.4k $934.0k | New |
| PERCEPTIVE ADVISORS LLC 0.01% of their portfolio | 27.0k $755.0k | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 24.4k $683.0k | New |
| Pinz Capital Management, LP 0.17% of their portfolio | 22.6k $634.0k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 16.4k $459.0k | New |
| Compagnie Lombard Odier SCmA 0.01% of their portfolio | 15.0k $422.0k | New |
| Zimmer Partners, LP 0.01% of their portfolio | 15.0k $420.0k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 13.9k $389.0k | New |
| Ensign Peak Advisors, Inc 0.00% of their portfolio | 5.0k $140.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 4.8k $135.0k | New |
| Davidson Kempner Capital Management LP 0.00% of their portfolio | 3.5k $98.0k | Not comparable |
| Rokos Capital Management LLP 0.00% of their portfolio | 2.5k $68.0k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 500 $14.0k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 116 $3.0k | New |
| UBS Group AG 0.00% of their portfolio | 32 $1.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |